体质量指数与下肢继发性淋巴水肿预后的分析

doi:10.3969/j.issn.1006-7795.2019.06.022

摘要/Abstract

摘要： 目的研究体质量指数（body mass index，BMI）对下肢继发性淋巴水肿肿胀程度和手术治疗预后的影响。方法分析2014年10月至2016年3月间于首都医科大学附属北京世纪坛医院行淋巴水肿手术治疗的96例下肢继发性淋巴水肿患者的临床资料，根据BMI分为正常组（BMI 18.5~23.9 kg/m²）25例、超重组（BMI 24.0~27.9 kg/m²）38例、肥胖组（BMI≥28.0 kg/m²）33例，比较3组患者术前及术后6个月患肢和健肢的周径差及体积差等临床资料。结果 3组患者的一般情况差异均无统计学意义（P>0.05）；而3组患者术前与术后6个月的患肢和健肢周径差、体积差差异均有统计学意义（P<0.001），肿胀均较术前明显缓解；肥胖组和正常组的术前患肢和健肢体积差、周径差、吸出脂肪量差异均有统计学意义（P<0.05）；超重组、肥胖组与正常组术后6个月的患肢和健肢体积差和周径差差异均有统计学意义（P<0.05）。结论 BMI与下肢继发性淋巴水肿肿胀程度和预后有密切关系，是影响肿胀程度和手术预后的重要指标之一。

关键词: 体质量指数, 继发性淋巴水肿, 肥胖, 肿胀程度, 预后

Abstract: Objective To study the effect of body mass index (BMI) on the degree of swelling and prognosis of patients with secondary lymphedema of lower extremities. Methods Retrospective analysis of the clinical data of 96 patients with secondary lymphedema of lower extremities at Department of Lymph Surgery, Beijing Shijitan Hospital, Capital Medical University from October 2014 to March 2016.They were divided into normal group (BMI 18.5-23.9 kg/m²,25 cases), overweight group (BMI 24.0-27.9 kg/m²,38 cases) and obesity group (BMI ≥ 28.0 kg/m²,33 cases). The clinical data of preoperative and postoperative were compared among the three groups. Results There were no significant differences in the general data of the three groups (P>0.05). Circumference and volume difference between pre-operation and 6 months after operation were significantly different (P<0.001) in three groups. There was a significant difference in fat aspiration, preoperative volume difference, preoperative circumference difference, volume difference of 6 months after surgery and circumference difference of 6 months after surgery between the obesity group and the normal group. There was a significant difference in volume difference of 6 months after surgery,and circumference difference of 6 months after surgery between the overweight group and the normal group. Conclusion BMI is associated with the degree of swelling and prognosis of secondary lymphedema in the lower extremities, and is an important predictor of the severity and surgical outcomes.

Key words: body mass index, secondary lymphedema, obesity, the degree of swelling, prognosis

中图分类号:

R654

苏万春, 孙宇光, 夏松, 信建峰, 常鲲, 沈文彬. 体质量指数与下肢继发性淋巴水肿预后的分析[J]. 首都医科大学学报, 2019, 40(6): 938-942.

Su Wanchun, Sun Yuguang, Xia Song, Xin Jianfeng, Chang Kun, Shen Wenbin. Analysis of body mass index and the prognosis of secondary lymphedema in lower extremities[J]. Journal of Capital Medical University, 2019, 40(6): 938-942.

参考文献

[1] Greene A K, Voss S D, Maclellan R A. Liposuction for swelling in patients with lymphedema[J]. N Engl J Med, 2017,377(18):1788-1789.
[2] Treves N. An evaluation of the etiological factors of lymphedema following radical mastectomy; an analysis of 1007 cases[J]. Cancer,1957,10(3):444-459.
[3] Vignes S, Porcher R, Champagne A, et al. Predictive factors of response to intensive decongestive physiotherapy in upper limb lymphedema after breast cancer treatment:a cohort study[J]. Breast Cancer Res Treat, 2006, 98(1):1-6.
[4] 中华医学会健康管理学分会, 中国营养学会, 中国医疗保健国际交流促进会生殖医学分会, 等. 超重或肥胖人群体重管理专家共识及团体标准[J]. 中华健康管理学杂志, 2018, 12(3):200-207.
[5] Sitzia J. Volume measurement in lymphoedema treatment:examination of formulae[J]. Eur J Cancer Care (Engl),19954(1):11-16.
[6] 顾景范. 《中国居民营养与慢性病状况报告(2015)》解读[J]. 营养学报, 2016,38(6):525-529.
[7] Dietz W H, Solomon L S, Pronk N, et al. An integrated framework for the prevention and treatment of obesity and its related chronic diseases[J]. Health Aff (Millwood), 2015, 34(9):1456-1463.
[8] Mehrara B J, Greene A K. Lymphedema and obesity:is there a link?[J]. Plast Reconstr Surg,2014,134(1):154e-160e.
[9] Helyer L K, Varnic M, Le L W, et al. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients[J]. Breast J, 2010, 16(1):48-54.
[10] Ridner S H, Dietrich M S, Stewart B R, et al. Body mass index and breast cancer treatment-related lymphedema[J]. Support Care Cancer, 2011, 19(6):853-857.
[11] Greene A K, Grant F D, Slavin S A, et al. Obesity-induced lymphedema:clinical and lymphoscintigraphic features[J]. Plast Reconstr Surg, 2015, 135(6):1715-1719.
[12] Arngrim N, Simonsen L, Holst J J, et al. Reduced adipose tissue lymphatic drainage of macromolecules in obese subjects:a possible link between obesity and local tissue inflammation?[J]. Int J Obes (Lond), 2013, 37(5):748-750.
[13] Shaw C, Mortimer P, Judd P A. A randomized controlled trial of weight reduction as a treatment for breast cancer-related lymphedema[J]. Cancer,2007, 110(8):1868-1874.
[14] Weitman E S, Aschen S Z, Farias-Eisner G, et al. Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes[J]. PLoS One,2013. 8(8):e70703.
[15] Aschen S, Zampell J C, Elhadad S, et al. Regulation of adipogenesis by lymphatic fluid stasis:part II. expression of adipose differentiation genes[J]. Plast Reconstr Surg,2012,129(4):838-847.
[16] 刘冰阳, 姜冉华,厉平,等.应用腰围身高比、腰臀比预测儿童青少年代谢综合征的最佳切点值的研究[J]. 中国医科大学学报,2017,46(5):434-438,443.
[17] 于砾淳, 龙波,孔慧敏,等.中国肥胖患者去脂体质量估算方程的研究[J]. 中国医科大学学报,2016,45(2):106-109.
[18] Duyur Cakit, B, Pervane Vural S, Ayhan F F. Complex decongestive therapy in breast cancer-related lymphedema:does obesity affect the outcome megatively?[J]. Lymphat Res Biol, 2019,17(1):45-50.
[19] Karppelin M, Siljander T, Vuopio-Varkila J, et al. Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients:a prospective case-control study[J]. Clin Microbiol Infect, 2010, 16(6):729-734.
[20] Vasileiou A M, Bull R, Kitou D, et al. Oedema in obesity; role of structural lymphatic abnormalities[J]. Int J Obes (Lond), 2011, 35(9):1247-1250.
[21] Brorson H, Ohlin K, Olsson G, et al. Breast cancer-related chronic arm lymphedema is associated with excess adipose and muscle tissue[J]. Lymphat Res Biol, 2009, 7(1):3-10.
[22] Kwan M L, Cohn J C, Armer J M, et al. Exercise in patients with lymphedema:a systematic review of the contemporary literature[J]. J Cancer Surviv, 2011, 5(4):320-336.
[23] Winkels R M, Sturgeon K M, Kallan M J, et al. The women in steady exercise research (WISER) survivor trial:The innovative transdisciplinary design of a randomized controlled trial of exercise and weight-loss interventions among breast cancer survivors with lymphedema[J]. Contemp Clin Trials,2017, 61:63-72.